Drug-related Dysgeusia: A Systematic Review
- 1 November 2018
- journal article
- review article
- Vol. 16 (6) , 499-507
- https://doi.org/10.3290/j.ohpd.a41655
Abstract
Purpose: Dysgeusia is an unpleasant alteration in taste. It can affect the nutritional and psychological status and decrease the quality of life of patients. It may be caused by nerve injury, head and neck trauma or surgery, infections, radiotherapy and drugs, but certain aetiological factors have not yet been identified. Understanding dysgeusia as a drug side effect is important for practitioners. The aim of this systematic review was to provide detailed information about dysgeusia in patients receiving different common medications. Materials and Methods: An electronic search was conducted in MEDLINE, Google Scholar and Scopus databases, and studies were selected according to our inclusion criteria. We included studies on human subjects that reported dysgeusia as a drug side effect. Results: Thirty-four eligible studies were included in the systematic review. Thirty-five drugs were found in the literature to be correlated to dysgeusia. The most commonly reported offending drugs were from keratolytic agents, chemotherapeutic and cancer medication, antihistamine, antibiotics and angiotensin-converting enzyme inhibitors. Conclusion: The quality of evidence was low in most reviewed studies. More studies with standard methodology are needed in this field. However, physicians and dental practitioners must consider the probability of dysgeusia as an adverse side effect when prescribing certain medications.Keywords
This publication has 34 references indexed in Scilit:
- Taste dysfunction: a practical guide for oral medicineOral Diseases, 2010
- A systematic review of dysgeusia induced by cancer therapiesSupportive Care in Cancer, 2010
- A Randomized, Double Blind, Placebo‐Controlled Study of MAP0004 in Adult Patients With MigraineHeadache: The Journal of Head and Face Pain, 2009
- Components of the anorexia–cachexia syndrome: gastrointestinal symptom correlates of cancer anorexiaSupportive Care in Cancer, 2009
- Oral manifestations of adverse drug reactions: guidelinesJournal of the European Academy of Dermatology and Venereology, 2008
- A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignanciesCancer Chemotherapy and Pharmacology, 2008
- Inflammation Activates the Interferon Signaling Pathways in Taste Bud CellsJournal of Neuroscience, 2007
- Combined Ciprofloxacin and Tinidazole Therapy in the Treatment of Chronic Refractory PouchitisDiseases of the Colon & Rectum, 2007
- Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell CarcinomaThe Oncologist, 2007
- Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancerLung Cancer, 2004